BARCLAYS PLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 109 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$3,376
-71.4%
65,055
-67.0%
0.00%
-71.4%
Q2 2023$11,821
+17.8%
197,141
-2.9%
0.01%
+40.0%
Q1 2023$10,036
-10.8%
202,984
+3.0%
0.01%0.0%
Q4 2022$11,250
-64.8%
197,128
+29234.5%
0.01%
Q3 2022$32,000
+10.3%
672
-13.4%
0.00%
Q2 2022$29,000
-12.1%
776
-30.0%
0.00%
Q1 2022$33,0001,1080.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders